LegoChem Biosciences
Jeiwook Chae is currently the Executive Vice President Business Development at LegoChem Biosciences. Prior to that, Jeiwook Chae was the Head of R&D, New Drug Development at Bioneer. With a background in Developmental Biology, Jeiwook Chae previously worked as a Postdoctoral Research Fellow at Harvard University. Jeiwook Chae earned a Doctor of Philosophy (Ph.D.) from the University of Virginia.
This person is not in any offices
LegoChem Biosciences
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).